CardioComm Solutions, Inc.
CardioComm Solutions, Inc. (EKGGF) Financial Performance & Income Statement Overview
Explore the financials of CardioComm Solutions, Inc. (EKGGF), including yearly and quarterly data on income, cash flow, and balance sheets.
CardioComm Solutions, Inc. (EKGGF) Income Statement & Financial Overview
Analyze CardioComm Solutions, Inc.’s EKGGF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $170391.00 | $140020.00 | $99202.00 | $117063.00 |
| Cost of Revenue | $14624.00 | $492.00 | $1865.00 | $127652.00 |
| Gross Profit | $155767.00 | $139528.00 | $97337.00 | -$10589.00 |
| Gross Profit Ratio | $0.91 | $1.00 | $0.98 | -$0.09 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $194146.00 | $171482.00 | $141964.00 | $82548.00 |
| Operating Expenses | $174028.00 | $181453.00 | $205177.00 | $82548.00 |
| Total Costs & Expenses | $188652.00 | $181945.00 | $207042.00 | $210201.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $7867.00 | $7040.00 | $7040.00 | $7040.00 |
| EBITDA | $94124.00 | -$34885.00 | -$100800.00 | -$86098.00 |
| EBITDA Ratio | $0.55 | -$0.25 | -$1.02 | -$0.74 |
| Operating Income | -$18261.00 | -$41925.00 | -$107840.00 | -$93140.00 |
| Operating Income Ratio | -$0.11 | -$0.30 | -$1.09 | -$0.80 |
| Other Income/Expenses (Net) | -$74413.00 | -$35591.00 | $37966.00 | $138626.00 |
| Income Before Tax | -$92674.00 | -$77516.00 | -$69874.00 | $45488.00 |
| Income Before Tax Ratio | -$0.54 | -$0.55 | -$0.70 | $0.39 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$36236.00 |
| Net Income | -$92674.00 | -$77516.00 | -$69874.00 | $45488.00 |
| Net Income Ratio | -$0.54 | -$0.55 | -$0.70 | $0.39 |
| EPS | -$0.001 | -$0.00 | -$0.001 | $0.00 |
| Diluted EPS | -$0.001 | -$0.00 | -$0.001 | $0.00 |
| Weighted Avg Shares Outstanding | $180.09M | $188.97M | $151.16M | $151.16M |
| Weighted Avg Shares Outstanding (Diluted) | $180.09M | $188.97M | $151.16M | $151.16M |
Over the last four quarters, CardioComm Solutions, Inc.'s revenue moved from $117063.00 in Q1 2024 to $170391.00 in Q4 2024. Operating income in Q4 2024 was -$18261.00, with a strong operating margin of -11%. Despite fluctuations in R&D and SG&A expenses, EBITDA for CardioComm Solutions, Inc. remained robust at $94124.00, reflecting operational efficiency. Net income dropped to -$92674.00, with an EPS of -$0.001. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan